You are cordially invited by your Bristol Myers Squibb
representative to attend a presentation that will focus on:
A Treatment Option for Patients with Metastatic NSCLC Regardless of PD-L1 Expression & Unresectable or Metastatic Melanoma regardless of BRAF status
Program Faculty:
Jeremy L Rosiecki, PA MPH
Physician Assistant Certified
Alaska Oncology and Hematology
Anchorage, AK
To RSVP
To register online, click the link below or scan the QR code
https://myattendeeresource.com/BMS/23121L1-BMS-93312
Or Email William Johanson at william.johanson@bms.com
Or call 1-866-326-7600 during the hours of 8:30 am to 5:00 pm EST,
Monday–Friday, and refer to meeting ID 23121L1-BMS-93312